Merck price target lowered to $125 from $130 at Citi
Citi lowered the firm’s price target on Merck (MRK) to $125 from $130 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the firm ...
Wells Fargo Sticks to Their Hold Rating for Merck & Company (MRK)
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Merck & Company (MRK – Research Report). The ...
pharmaphorum22h
Merck turns to cardiovascular pipeline for its post-Keytruda future
During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...
Reuters22h
Global Market Headlines | Breaking Stock Market News | Reuters
Deepseek logo and rising stock graph are seen in this illustration taken, January 27, 2025. REUTERS/Dado Ruvic/Illustration/File Photo ...